Alector, Inc. (ALEC) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $11.00K; Additional Paid in CapitalUSD $1.01B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-126.00K; Retained Earnings (Accumulated Deficit)USD $-1.02B.
- 2026-03-31: Common Stock, Value, IssuedUSD $11.00K; Additional Paid in CapitalUSD $1.01B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-104.00K; Retained Earnings (Accumulated Deficit)USD $-994.99M.
- 2025-12-31: Common Stock, Value, IssuedUSD $11.00K; Additional Paid in CapitalUSD $1.00B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $166.00K; Retained Earnings (Accumulated Deficit)USD $-972.06M.
- 2025-09-30: Common Stock, Value, IssuedUSD $10.00K; Additional Paid in CapitalUSD $992.29M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $197.00K; Retained Earnings (Accumulated Deficit)USD $-934.79M.
Alector, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11.00K | $1.01B | $-126.00K | $-1.02B | $-9.97M | 3 month · $2.61M |
| 2026-03-31 | $11.00K | $1.01B | $-104.00K | $-994.99M | $10.38M | 3 month · $2.91M |
| 2025-12-31 | $11.00K | $1.00B | $166.00K | $-972.06M | $30.65M | 12 month · $26.66M |
| 2025-09-30 | $10.00K | $992.29M | $197.00K | $-934.79M | $57.71M | 3 month · $6.40M |
| 2025-06-30 | $9.00K | $971.19M | $96.00K | $-900.12M | $71.17M | 3 month · $7.06M |
| 2025-03-31 | $9.00K | $964.01M | $191.00K | $-869.60M | $94.61M | 3 month · $8.35M |
| 2024-12-31 | $9.00K | $955.66M | $261.00K | $-829.13M | $126.80M | 12 month · $39.46M |
| 2024-09-30 | $9.00K | $945.05M | $931.00K | $-827.05M | $118.93M | 3 month · $9.04M |
| 2024-06-30 | $9.00K | $936.01M | $-620.00K | $-784.83M | $150.57M | 3 month · $9.91M |
| 2024-03-31 | $9.00K | $925.46M | $-403.00K | $-746.16M | $178.91M | 3 month · $10.31M |
| 2023-12-31 | $8.00K | $844.04M | $184.00K | $-710.08M | $134.16M | 12 month · $42.80M |
| 2023-09-30 | $8.00K | $831.91M | $-721.00K | $-668.64M | $162.56M | 3 month · $10.06M |
| 2023-06-30 | $8.00K | $821.85M | $-1.39M | $-624.17M | $196.31M | 3 month · $10.22M |
| 2023-03-31 | $8.00K | $810.75M | $-2.20M | $-625.54M | $183.01M | 3 month · $10.97M |
| 2022-12-31 | $8.00K | $798.70M | $-4.58M | $-579.69M | $214.44M | 12 month · $46.15M |
| 2022-09-30 | $8.00K | $787.10M | $-6.74M | $-527.26M | $253.10M | 3 month · $10.77M |
| 2022-06-30 | $8.00K | $775.84M | $-6.22M | $-481.11M | $288.52M | 3 month · $12.48M |
| 2022-03-31 | $8.00K | $762.46M | $-3.94M | $-490.99M | $267.54M | 3 month · $11.94M |
| 2021-12-31 | $8.00K | $748.04M | $-943.00K | $-446.38M | $300.72M | 12 month · $40.78M |
| 2021-09-30 | $8.00K | $726.69M | $-41.00K | $-390.77M | $335.89M | 3 month · $10.20M |
| 2021-06-30 | $8.00K | $701.67M | $203.00K | $-517.37M | $184.51M | 3 month · $9.08M |
| 2021-03-31 | $8.00K | $689.63M | $410.00K | $-462.22M | $227.83M | 3 month · $8.80M |
| 2020-12-31 | $8.00K | $676.96M | $614.00K | $-410.05M | $267.53M | 12 month · $30.52M |
| 2020-09-30 | $8.00K | $666.96M | $1.09M | $-357.87M | $310.19M | 3 month · $8.03M |
| 2020-06-30 | $8.00K | $658.64M | $1.85M | $-305.17M | $355.33M | 3 month · $6.95M |
| 2020-03-31 | $8.00K | $648.78M | $2.78M | $-259.84M | $391.73M | 3 month · $6.64M |
| 2019-12-31 | $7.00K | $414.41M | $142.00K | $-219.82M | $194.74M | 12 month · $16.28M |
| 2019-09-30 | $7.00K | $407.65M | $226.00K | $-189.29M | $218.59M | 3 month · $4.10M |
| 2019-06-30 | $7.00K | $402.82M | $441.00K | $-157.56M | $245.72M | 3 month · $3.69M |
| 2019-03-31 | $7.00K | $399.07M | $108.00K | $-133.00M | $266.19M | 3 month · $3.25M |
| 2018-12-31 | $1.00K | $17.08M | $-42.00K | $-114.44M | $-97.40M | 12 month · $6.92M |
| 2018-09-30 | (m) | (m) | (m) | (m) | $-82.78M | 3 month · $1.98M |
| 2018-06-30 | (m) | (m) | (m) | (m) | $-69.40M | 3 month · $1.16M |
| 2018-03-31 | (m) | (m) | (m) | (m) | $-59.50M | 3 month · $1.12M |
| 2017-12-31 | (m) | (m) | (m) | (m) | $-52.03M | 12 month · $5.35M |
| 2016-12-31 | (m) | (m) | (m) | (m) | $-24.91M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |